A general method to eliminate laboratory induced recombinants during massive, parallel sequencing of cDNA library. by Waugh,C et al.
		
 
 
 
 
 
 
 
 
 
This is the published version 
 
Waugh,C, Cromer,D, Grimm,A, Chopra,A, Mallal,S, Davenport,M and Mak,J 
2015, A general method to eliminate laboratory induced recombinants during 
massive, parallel sequencing of cDNA library., Virology Journal, vol. 12, no. 1, 
pp. 55. 
 
 
 
 
 
 
Available from Deakin Research Online 
 
http://hdl.handle.net/10536/DRO/DU:30072620	
	
	
	
	
	
	 	
Reproduced with the kind permission of the copyright owner 
	
	
 
 
 
 
 
Copyright: 2015, BioMed Central 
 
Waugh et al. Virology Journal  (2015) 12:55 
DOI 10.1186/s12985-015-0280-xMETHODOLOGY Open AccessA general method to eliminate laboratory
induced recombinants during massive, parallel
sequencing of cDNA library
Caryll Waugh1,2, Deborah Cromer3, Andrew Grimm3, Abha Chopra4, Simon Mallal4, Miles Davenport3*
and Johnson Mak1,2*Abstract
Background: Massive, parallel sequencing is a potent tool for dissecting the regulation of biological processes by
revealing the dynamics of the cellular RNA profile under different conditions. Similarly, massive, parallel sequencing
can be used to reveal the complexity of viral quasispecies that are often found in the RNA virus infected host. However,
the production of cDNA libraries for next-generation sequencing (NGS) necessitates the reverse transcription of RNA into
cDNA and the amplification of the cDNA template using PCR, which may introduce artefact in the form of phantom
nucleic acids species that can bias the composition and interpretation of original RNA profiles.
Method: Using HIV as a model we have characterised the major sources of error during the conversion of viral RNA to
cDNA, namely excess RNA template and the RNaseH activity of the polymerase enzyme, reverse transcriptase. In addition
we have analysed the effect of PCR cycle on detection of recombinants and assessed the contribution of transfection of
highly similar plasmid DNA to the formation of recombinant species during the production of our control viruses.
Results: We have identified RNA template concentrations, RNaseH activity of reverse transcriptase, and PCR conditions
as key parameters that must be carefully optimised to minimise chimeric artefacts.
Conclusions: Using our optimised RT-PCR conditions, in combination with our modified PCR amplification procedure,
we have developed a reliable technique for accurate determination of RNA species using NGS technology.
Keywords: HIV, Recombination rate, Mutation rate, TransfectionBackground
The massive capacity of next generation sequencing
(NGS) technologies is revolutionising transcriptome
analysis and can be used to assess the complexity of viral
diversity in highly mutable, genomes of RNA viruses that
cause disease in humans, such as human immunodeficiency
virus-1 (HIV-1). Accurate detection of clinically relevant,
drug-resistant mutations is important for adapting patient
drug regimes. In addition, deep sequencing is used to
investigate host cell and viral factors that impact on the
genetic diversity of HIV-1.* Correspondence: M.Davenport@unsw.edu.au; j.mak@deakin.edu.au
3Centre for Vascular Research, University of NSW, Sydney, NSW, Australia
1School of Medicine, Deakin University and CSIRO(AAHL), Geelong, VIC,
Australia
Full list of author information is available at the end of the article
© 2015 Waugh et al.; licensee BioMed Central
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.The production of cDNA libraries for NGS involves
laboratory procedures that include RNA extraction,
reverse transcription PCR (RT-PCR) to generate cDNA
followed by PCR amplification. Importantly, the amplifica-
tion of each cDNA species must remain clonal, especially
when studying the diversity of RNA species. The laboratory
manipulations necessary for library generation are recog-
nised as potential sources of artefactual recombination.
Several papers have addressed the issue of minimising PCR
artefacts [1-3] and there is growing interest in optimising
RT-PCR techniques to enable accurate analysis of patient
RNA virus load and early detection of the emergence of
drug resistant quasi-species [3-6].
Thus, in both the clinical and experimental setting
there is a recognised need to identify sources of laboratory
induced error and to minimise these to obtain a robust
technique for generating DNA libraries for NGS that. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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virus. In the current study there were three aspects of
sample processing that we were particularly interested in
assessing and optimising: RNA concentration during
first strand synthesis; effect of RNase H activity and
PCR cycling conditions. To assess the impact of these
on the introduction of recombinant artefact we used
a mix of authentic wild-type (WT) HIV-1 and marker
virus containing silent mutations[7] that are ideal for
assessing sources of laboratory induced recombination
events during cDNA library preparation. The marker
virus is biologically and functionally indistinguishable
from the parental WT virus, and thus mimics the closely
related, yet genetically distinct, quasi-species that exist in
infected patients.
Using our viral system we have produced populations of
genetically distinct, but functionally identical, homozygous
HIV-1 particles (containing either WT or marker RNA)
and also heterozygous HIV-1 (containing a strand of WT
and marker RNA) as sources of viral RNA species for
analysis of laboratory sources of recombination. We
have characterised the important sources of error in
RT-PCR that contribute to artificial chimera formation
and, in combination with our modified PCR amplification
procedure [1] and analytic tools [7], have developed a
reliable technique for accurate determination of viral
diversity using NGS. Our key observations are that (i)
the amount of RNA used in the reverse transcription
PCR must be kept to a minimum; (ii) approximately
2,500 copies of cDNA should be input into the PCR
amplification step and (iii) PCR cycles should be optimised
so that the amplification reaction is stopped whilst still in
the linear phase (27–29 cycles). Furthermore, we have also
shown that homologous recombination during transfection,
sometimes perceived as a source of experimental biasFigure 1 Experimental method for assessing transfection as a source
cells, harvested and quantitated using an ELISA assay to detect HIV-1 p24CA
amounts of homozygous WT and homozygous MK virus (top) or from an eduring virus production [8-11], is a negligible source
of error and the effect of laboratory manipulations on
estimates of mutation rate can be readily managed with
appropriate rigorous experimental procedure.
Results and discussion
Increasing RNA concentration correlates with artificial
chimera formation in reverse transcription PCR (RT-PCR)
Many groups have exploited the depth and sensitivity of
NGS to characterise viral quasispecies in patient samples
especially to identify rare HIV-1 variants and clinically
important drug resistant mutations [3-6]. Where plasma
or tissue viral load is low, it is imperative that efforts to
maximise cDNA product for analysis, such as increasing
(a) the amount of RNA that is reverse transcribed or (b)
the amplification cycles during PCR, do not compromise
the original virus population species. To estimate the
effect of initial RNA concentration on the detection
of chimeric recombinants an equal amount (based on
viral protein p24CA) of homozygous WT and MK viruses
were mixed together and RNA extracted (Figure 1 top).
First strand synthesis was performed with three different
concentrations of starting material using the high fidelity
SSIII RT. RNA was added to the reverse transcription reac-
tion mix at 160 ng, 1600 ng or 3990 ng, the maximum
amount possible in this experiment given the concentra-
tion of the extracted RNA. It should be noted that these
amounts are within the range recommended by the
manufacturer (1 pg – 5ug). In order to stress the RT-PCR
conditions and to mimic the effect of excessive template,
at the highest template concentration (3990 ng), gene
specific primers and dNTP’s were reduced 4-fold.
The recombination events per 1000 nucleotides (REPN)
increased significantly as RNA concentration increased for
RNA extracted from the mix of WT and MK virusof artificial chimeras. Virus was produced by transfection of HEK293T
protein. In these studies RNA was extracted from either a mix of equal
quivalent amount of heterozygous virus (bottom).
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relevant sequences retrieved from 454 sequencing declined
as the RNA input template increased and notably, the
greatest proportion of truncated sequences and the lowest
proportion of sequences suitable for analysis occurred at
the highest input template (data not shown). There was a
less pronounced effect on mutation with similar rates
for low and mid-range input RNA templates, rising
approximately 3-fold at the highest input template
(Table 1b and Figure 2b). These data indicate that the
concentration of RNA during reverse transcription can
have a profound effect on the quantity and quality of
sequencing data, can promote formation of artificial
chimeras but has less impact on mutation rate.
Effect of PCR cycling conditions on chimera formation
It has been shown that PCR conditions have a significant
impact on the detection of genomic recombinants [1].
Smyth et al. have developed modified cycling conditions
to minimise the occurrence of chimeras during PCR. We
sought to estimate the cumulative effects of optimal ver-
sus non-optimal RT-PCR followed by optimal and non-
optimal PCR conditions. RNA was reverse transcribed, as
described, varying the input amounts in the RT-PCR andTable 1 Recombination and mutation rates
a. Recombination rates
RNA (ng) RT Virus PCR Cycles
160 SSIII wt + mk mix 27
1600 SSIII wt + mk mix 27
3990 SSIII wt + mk mix 27
2000 AMV wt + mk mix 27
160 SSIII Heterozygous 27
160 SSIII wt + mk mix 35
1600 SSIII wt + mk mix 35
3990 SSIII wt + mk mix 35
b. Mutation Rates
RNA (ng) RT Virus PCR Cycles
160 SSIII wt + mk mix 27
1600 SSIII wt + mk mix 27
3990 SSIII wt + mk mix 27
2000 AMV wt + mk mix 27
160 SSIII Heterozygous 27
160 SSIII wt + mk mix 35
1600 SSIII wt + mk mix 35
3990 SSIII wt + mk mix 35
RNA was extracted from either an equal mix of homozygous WT and MK viruses or
using increasing amounts of RNA as template using SSIII reverse transcriptase (RT),
was also reverse transcribed using AMV with intact RNase H activity. Following first
or 35 PCR cycles. Replicates containing SYBR Green 1 dye were used to ensure the
(35 cycles). Replicate samples were pooled and prepared for 454 NGS sequencing. R
The 95% confidence interval lower and upper boundaries, as determined by bootstthen diluted aliquots of cDNA were amplified with PCR
using identical conditions other than the number of
amplification cycles. PCR amplification was performed
with optimised cycles, where the amplification process
was terminated in the linear phase (25–28 cycles), or
allowing the PCR to run to plateau (35 cycles). Amp-
lification was followed in real time by monitoring dupli-
cate samples that contained the fluorescent dye SYBR
Green 1. As expected, allowing the PCR amplification to
run to ‘completion’ resulted in significant increases in
recombination rate in all cases (Table 1a compare 27
cycles to 35 cycles and Figure 3a). The number of PCR
cycles had very little impact on mutation rate
(Table 1b and Figure 3b).
RNAse H activity has minor impact on chimera formation
The HIV-1 genome is comprised of 2 identical (or near
identical) strands of RNA, that are used as template
during reverse transcription to produce a cDNA molecule
for integration into the host genome during infection.
Template switching during reverse transcription is ac-
knowledged as an efficient mediator of viral diversity, gen-
erating recombinant HIV RNA species that are a
mixture of the two parental RNA strands. TemplateRR Lower 95% CI bound Upper 95% CI bound
0.0065 0.0000 0.0132
0.1029 0.0787 0.1391
0.8933 0.3675 1.8378
0.0742 0.0640 0.0901
0.0128 0.0064 0.0248
2.9482 2.7699 3.1668
4.6068 4.4601 4.7671
1.061 0.7903 1.4239
MR Lower 95% CI bound Upper 95% CI bound
0.1198 0.1075 0.1325
0.1551 0.1340 0.1763
0.4549 0.2674 0.6702
0.2169 0.2053 0.2288
0.1658 0.1503 0.1811
0.2172 0.1959 0.2396
0.1608 0.1494 0.1717
0.2819 0.2483 0.3166
from an equivalent amount of heterozygous virus and reverse transcribed
engineered to have minimal RNase H activity. In a parallel experiment RNA
strand synthesis, cDNA was diluted as appropriate and amplified using 27
reaction was stopped while in the log linear phase (27 cycles) or at plateau
ecombination and mutation rates are expressed as rate per 1000 nucleotides.
rapping, are shown for each estimate.
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Figure 2 Effect of RNA concentration on (a) recombination and (b) mutation rates. RNA was extracted from an equal mix of WT and MK
virus. SSIII was used to reverse transcribe 160 ng, 1600 ng or 3990 ng as input template. At the highest RNA concentration dNTP’s and primers
were reduced 4-fold to mimic the effect of excess RNA template. Resulting cDNA was diluted such that ~2500 copies were input and amplified using
an optimised 2-step PCR and reduced (27) cycles to minimise PCR-induced recombination [1]. Recombination and mutation rates are expressed as rate
per 1000 nucleotides and the confidence intervals, as estimated via bootstrapping, are shown. Significant differences (at 95%CI) are indicated.
Waugh et al. Virology Journal  (2015) 12:55 Page 4 of 10switching is thought to be facilitated through the action of
the RNase H activity of the HIV-1 RT whereby a dynamic
balance exists between the polymerase activity of RT and
the endonuclease activity of RNase H that cleaves the
RNA from the nascent cDNA polymer [12,13]. According
to the copy-choice model, RNase H degrades the RNA
template from the RNA/cDNA hybrid thus permitting
the newly synthesised DNA to base-pair with the similar
sequence on the other RNA strand.
As the aim of this study was to identify optimal
processes for minimising laboratory induced artefact
we performed a comparative analysis of AMV with
SSIII. To assess the in vitro effect of RNase H activity
on the formation of artificial recombinants viral RNA
was reverse transcribed using either the high fidelity
SSIII enzyme, engineered to have reduced RNase H
activity, or AMV RT with full RNase H activity. We
compared the recombination rates detected for 160
ng and 1600 ng of RNA transcribed with SSIII with
the rate for 2ug RNA transcribed using AMV-RT, as160 1600 3990
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Figure 3 Effect of PCR cycle on (a) recombination and (b) mutation ra
Resulting cDNA was diluted as described and amplified using a 2-step PCR an
and mutation rates are expressed as rate per 1000 nucleotides and the confid
differences (at 95%CI) are indicated.recommended by the manufacturer. Surprisingly, the
RNase H activity of AMV had little impact on the re-
combination rate when compared to 1600 ng of RNA
transcribed with SSIII, however both of these were
10-fold higher than the recombination rate at 160 ng
input RNA using SSIII (Table 1 and Figure 4a). These
results further emphasise the influence of RNA concentra-
tion on recombination during first strand synthesis. The
mutation rate was similar for both enzymes (Table 1 and
Figure 4b) and, in contrast to the recombination rate, was
not significantly affected by RNA concentration.
Transfection of HEK293T cells does not contribute
significantly to chimera formation
Several groups have developed experimental protocols to
measure recombination rates of HIV-1 and other viruses
that require the production of virus from producer cell
lines using standard transfection methods and then use
of the virus to infect cell lines and primary cells [14-17].
Thus, transfection presents another potential source of160 1600 3990
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tes. RNA was extracted and transcribed as described in Figure 2.
d either 27 cycles (white bars) or 35 cycles (black bars). Recombination
ence intervals, as estimated via bootstrapping, are shown. Significant
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Figure 4 Effect of RNase H activity on (a) recombination and (b) mutation. RNA was extracted from an equal mix of WT and MK virus. SSIII
was used to reverse transcribe 160 ng and 1600 ng as input template and AMV was used to reverse transcribe 2000 ng. All conditions complied
with the manufacturers recommendations. Resulting cDNA was diluted and amplified using an optimised 2-step PCR and 27 cycles to minimise
PCR-induced recombination [1]. Recombination and mutation rates are expressed as rate per 1000 nucleotides and the confidence intervals,
as estimated via bootstrapping, are shown. Significant differences (at 95% CI) are indicated.
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shown that mammalian cells possess the enzymatic ma-
chinery to effect homologous recombination and that
(i) DNA topology affects homologous recombination
with linear molecules the preferred substrates [9], (ii)
homologous recombination can occur between single
stranded and double stranded DNA [10] and (iii) nicked
DNA significantly enhances the frequency of homologous
recombination in transfected cells [8,11]. Our system of
marker and wild type plasmids provides a unique oppor-
tunity to assess the role of homologous recombination as
a source of chimeric artefact during transfection.
HEK293T cells were transfected with proviral DNA plas-
mids to produce control viruses. We extracted RNA from
either an equal mixture of homozygous WT and homozy-
gous MK viruses (Figure 1 top) or from heterozygous
WT/MK virus (based on p24 values) (Figure 1 bottom).
Our sequencing data reveals that the heterozygous virus is
composed of ~50% WT: 50%MK HIV-1 sequences (data
not shown). This is consistent with the premise that the
plasmids used in transfection were equally transcribed.
Given that: (i) the WT and MK plasmids were transfected
in equal ratios, (ii) each virion contains two copies of
RNA and (iii) the heterozygous virus also has equal ratios
of WT and MK virus, then the simplest and most likely
scenario is that 25% of virions contain two copies of WT
virus, 25% of virions contain two copies of MK virus and
50% of virions contain one copy of WT virus and one
copy of MK virus. Any other scenario is less likely and
would require special pleading, and therefore we believe
that our Mendelian assumption is valid. This is also
consistent with data published by Chen et al. [18] who
were able to directly discriminate between two different
RNA molecules encapsidated within the same virion par-
ticle and confirmed that, using standard transfection
techniques, RNA co-packaging was an efficient process
(more than 90% of virions contained RNA) and that ~48%of virions that contained RNA were heterozygous, as pre-
dicted by the Hardy-Weinberg model.
Samples were prepared using optimised RT-PCR (160 ng
input RNA template) and resulting cDNA was diluted
so that approximately 2,500 copies of HIV-1 cDNA
were used as template and amplified using our opti-
mised PCR protocols. The mixture of homozygous
RNA species provides a baseline measure of artefac-
tual recombination attributable to downstream labora-
tory manipulations, as any recombination between
these homozygous viruses could only have occurred
during RT-PCR, PCR or 454 sequencing. Thus, com-
parison of the rate of recombination between the mix
of homozygous viruses (equal mix of WT plus MK) with
that of the truly heterozygous viral RNA provides a novel
and accurate estimate of the rate of transfection-induced
recombination.
Table 1 and Figure 5 show that the detection of recom-
binant species in the heterozygous virus was extremely low
and less than 2-fold higher than the mix of viruses. These
results are consistent with those of Levy et al. [14] who
used a GFP reporter system and found that recombination
within transfected cells to generate heterozygous viruses
resulted in approximately 0.33% of the producer cells
exhibiting GFP fluorescence. Taken together, the data
indicate that the predominant sources of artefactual
recombination are the RT-PCR and PCR steps and
that increasing input RNA in the RT-PCR step and
using sub-optimal PCR conditions contribute signifi-
cantly to the formation of chimeric species detectable
by deep sequencing.
Conclusions
Any analysis of viral diversity through experimentation
raises the possibility that recombinant quasi-species could
arise as a result of laboratory manipulations, including
virus production (transfection), infection of primary cells
WT+MK mix WT/MK het
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Figure 5 Occurrence of transfection induced recombination.
Homozygous and heterozygous viruses were produced by transfection
of HEK293T cells as described in the methods. RNA was extracted from
an equal mix of WT and MK virus or from an equivalent amount of
heterozygous virus. In parallel reactions SSIII was used to reverse
transcribe 160 ng as input template. Resulting cDNA was diluted and
amplified using an optimised 2-step PCR and 27 cycles to minimise
PCR-induced recombination [1]. Any recombination occurring in the
mix of homozygous viruses can only be a consequence of RT-PCR,
PCR and/or 454 sequencing (laboratory induced recombination).
Recombination in the heterozygous virus reflects both laboratory
induced recombination and transfection induced recombination.
Recombination and mutation rates are expressed as rate per 1000
nucleotides and the confidence intervals as estimated via
bootstrapping are shown. There was no significant difference
between these estimates.
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cDNA (RT-PCR) and cDNA amplification. Mutations
in the form of insertions, deletions or substitutions
could occur during any of these procedures and deep
sequencing. Further, with the vast improvements in
treatment for HIV-1 infection that have occurred over
the last 30 years, clinicians are now able to investi-
gate the emergence of viral quasi-species in individual
patients and to tailor drug regimes to counter the
emergence of deleterious, drug-resistant mutants. Ex-
perimental programs to identify viral and host cell
factors that affect recombination and clinical assessments
of drug-resistant mutants require sensitive and validated
methods to discern ‘true’ in vivo viral species from labora-
tory induced artefacts.
We produced genetically distinct, authentic HIV-1
viruses to investigate the most obvious sources of
laboratory induced error, namely: transfection, RT-PCRand PCR conditions. Using our system we have been
able to compare recombination rates between a mix
of homozygous viruses (where recombination could only
be due to laboratory manipulations) and heterozygous
virus (where recombination could be due to laboratory
manipulations or to the transfection process). Our data
show that the transfection of HEK293T cells with plasmid
DNA is an insignificant source of recombination and
affirms the appropriateness of using transfection-derived
viruses as model systems to identify viral and host
cell factors that affect recombination. We stress the
importance of using high quality plasmid DNA for the
production of virus to minimise the risk of homologous
recombination within the culture system. This is consistent
with previous studies that have shown that nicked,
non-circular plasmid DNA enhances the occurrence
of homologous recombination between plasmid and
homologous chromosomal regions [8,10].
By comparison considerable attention must be paid to
the conditions of RT-PCR and PCR to minimise the
occurrence of artefactual chimeras. We postulated
that increasing the concentration of RNA during first
strand synthesis would decrease the proximal distance
of strands of RNA and enhance strand transfer events,
thus resulting in increased recombination rates. Our data
confirm that RNA concentration in RT-PCR is a critical
parameter. Surprisingly, even acceptable ‘mid-range’
concentrations of RNA template (1600 ng, well within
the manufacturer’s suggested range) at the RT-PCR
step can result in detection of false chimeras. Thus
we show that even when using a high fidelity enzyme
with low RNase H activity, RNA concentration is a
critical factor and can have a marked effect on estimates
of recombination rate. We recommend that input RNA be
kept to a minimum (100-200 ng) which, in this study,
is at least 10-fold lower than that recommended by
the manufacturer. In accord with Di Giallonardo et al. [2],
we have found that RNaseH activity does not contribute
significantly to artificial recombination when the concen-
tration of RNA template is low.
The PCR amplification of DNA is highly susceptible to
artefact. Previous studies have shown that input copy
number [1,2], annealing and extension steps [1] and
number of PCR cycles [1,3] are critical parameters,
requiring optimisation to minimise formation of artificial
chimeras. In this study we used a 2-step PCR with opti-
mised, limited input copy number (~2500 copies), shown
to minimise artificial chimeras [1]. Varying only the number
of PCR cycles performed, we have shown that stopping the
PCR amplification in the linear phase minimises false
recombinants whereas increasing cycle number to 35
dramatically increased the detection of false chimeras. Our
data show directly that while increasing the input RNA
concentration and PCR cycle might generate a larger viral
Waugh et al. Virology Journal  (2015) 12:55 Page 7 of 10cDNA population for analysis, such an approach is
likely to compromise the quality of sequencing data
obtained. We have used the data to develop a protocol
that minimises the introduction of artificial recombinants
during 454 library generation. The salient features of our
protocol are: (i) restricted RNA input (100-200 ng) at
RT-PCR for first strand synthesis using a high fidelity
RT; (ii) ~2,500 copies of cDNA used as template for
subsequent PCR amplification; and (iii) restricting PCR
cycles to ~27-29 cycles to ensure that the amplification
process is terminated in the linear phase of amplification.
These studies have direct relevance to the clinical set-
ting where minimisation of artefact is essential to obtain-
ing accurate measurements of viral diversity and
detection of drug resistant mutations. The articulation
of these critical parameters (RNA concentration, choice of
enzyme, input cDNA copies and PCR cycling parameters)Figure 6 Measurement of recombination and mutation rates. (Top) Al
and corresponding marker sequence (bottom line) showing the 15 silent m
spaced approximately 50 nucleotides apart (range 18 to 156 nucleotides). N
identical sequence and silent mutations are indicated with orange highligh
silent markers (red) and positions of the overlapping amplicons (brown barinforms our own program of experimental research to
identify viral and host cell factors that impact recombin-
ation rate and viral diversity.
Methods
Molecular clones
The wild-type (WT) HIV-1 plasmid used was pDRNL
(AD8) [19] that encodes an R5-tropic strain of HIV-1.
A modified, ‘marker’ version of this plasmid (MK) was
created by introducing 15 pairs of silent genetic marker
points by nucleotide substitution into gag, as previously
described [1,20,21] and depicted in Figure 6. This created
a total of 13 intervals spaced, on average about 50
nucleotides apart where recombination can be measured.
Importantly, the marker points did not change the protein
profile of the virus, the replication kinetics compared to
wild-type (WT) virus or known RNA sequence elementsignment of GAG1 region of HIV-1 WT sequence (pDRNL(AD8)) (top line)
utations introduced into adjacent codons. This created 14 intervals
umbering is based on the pDRNL(AD8) WT sequence. Dots indicate
t. (Bottom) Schematic representation of the marker system depicting
s) that enable detection of recombination events (Adapted from [20].
Waugh et al. Virology Journal  (2015) 12:55 Page 8 of 10[1,20,21]. It is important to note that this system does not
introduce ‘foreign’ genes into the HIV-1 genome, such as
fluorescent markers, antibiotic resistance genes or surface
protein markers that can drastically change the RNA
structure. Furthermore, the series of silent mutations
enables detection of recombination events over a signifi-
cant length of the genome (Figure 6) and unlike other
systems, also permits the identification of multiple
template switches. A full description of our system
and its attendant advantages in accurately measuring
recombination has been published [7,20].
Transfection and virus production
Homozygous virus was produced by transfection of
HEK293T cells with either WT or MK plasmid and
heterozygous virus by co-transfection of equimolar
amounts of WT and MK plasmids using polyethyleneimineTable 2 Primers used for amplicon generation
a. Barcode sequences
Barcode Sequence (5′→3′)
RL1 ACACGACGACT
RL2 ACACGTAGTAT
RL3 ACACTACTCGT
RL4 ACGACACGTAT
RL5 ACGAGTAGACT
RL6 ACGCGTCTAGT
RL7 ACGTACACACT
RL8 ACGTACTGTGT
RL9 ACGTAGATCGT
RL10 ACTACGTCTCT
RL11 ACTATACGAGT
RL12 ACTCGCGTCGT
RL13 AGACTCGACGT
RL14 AGTACGAGAGT
RL15 AGTACTACTAT
RL16 AGTAGACGTCT
b. HIV-1 sequences common to WT and MK transcripts
Primer Sequence
G1(2945)Fw 5′ GAGATGGGTGCGAGAGCGTC 3
G1(3314)Rv 5′ TGTGTCAGCTGCTGCTTGCTG 3′
G2(3236)Fw 5′ ACCAAGGAAGCCTTAGATAAGA
G2(3679)Rv 5′ TGAAGGGTACTAGTAGTTCCTGC
G3(3584)Fw 5′ GATAGATTGCATCCAGTGCATGC
G3(3955)Rv 5′ GCTTTTAAAATAGTCTTACAATC
G4(3793)Fw 5′ TCTGGACATAAGACAAGGACCA
G4(4195)Rv 5′ ACATTTCCAACAGCCCTTTTTCC
Barcoded primers were designed so that marker points were amplified as 4 overlap
(a) unique barcodes at the 5′ end; followed by (b) regions that were identical betwe(PEI; Polysciences). Based on Mendelian genetics, the
heterozygous virus will be composed of 3 distinct popula-
tions: 25% of virus particles will contain 2 strands of WT
RNA; 25% will contain 2 strands of MK RNA and 50% will
be truly heterozygous, containing a strand of WT and MK
RNA. Sixteen to twenty hours after transfection cell cul-
tures were gently washed with PBS and replenished with
fresh media. At 48 hr post-transfection viral supernatants
were harvested, clarified by centrifugation, layered
over a 20% sucrose cushion and centrifuged for 1 hour at
25,500 g, 4oC. Concentrated virus was then further
refined by layering onto a sucrose gradient (consisting
of 9 sucrose layers ranging from 50% sucrose to 32%
sucrose in 2.5% decrements) and centrifuged for 16 h,
25,500 g, 4°C to reduce plasmid contamination. Con-
centrated virus was resuspended in RPMI (Invitrogen),
aliquoted and stored at −80°C. Quantitation of virusAmplicon length (nt)
′ 370
TAGAGGAAGAG 3′ 444
TATGTCACTTC 3′
AG 3′ 372
TGGGTTCGC 3′
AAGG 3′ 403
TAG 3′
ping areas within the gag region of HIV-1. Primers were designed with
en both WT and MK cDNA sequence.
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protein using the HIV-1 p24CA Antigen Capture Assay
(Frederick National Laboratory-AIDS and Cancer virus
program).
RNA isolation and cDNA synthesis
Viral RNA was isolated using TRI-reagent (Qiagen)
according to the manufacturer’s recommendations. RNA
was reverse transcribed using gene-specific primer, gag4
(4195)Rv (5′ ACATTTCCAACAGCCCTTTTTCCTAG
3′), and either SuperScript III reverse transcriptase (RT)
(Invitrogen) engineered to have minimal RNaseH activity
or AMV RT (with RNAse H activity) (Promega). Variable
amounts of input RNA template were used in optimal
and ‘stress’ conditions, as described in the results section.
To gauge plasmid DNA contamination, RNA samples
were processed without reverse transcriptase (RT) and
then analysed by qPCR using primers for gag1 amplicon.
In all cases there was a minimum 10 cycle threshold
differences between samples processed with the RT and
those without, indicating very low levels of plasmid
contamination.
PCR primers
Barcoded PCR primers were designed so that marker
points were amplified as 4 overlapping amplicons
(~350 bp) covering the gag region of HIV-1 and desig-
nated gag1, gag2, gag3 and gag4. Primers were designed
with unique barcodes at the 5′ end (Table 2a) followed by
regions that were identical between WTand MK sequence
(Table 2b).
PCR amplification conditions
Modified PCR cycling conditions were used as described
previously [1] to reduce chimera formation during PCR
amplification. Briefly, the PCR mix (total volume, 15ul)
consisted of limiting DNA template (approximately
2,500 copies in 5 ul), 1x HF buffer (Thermo Scientific),
200uM dNTP (NEB), 400nM of each barcoded primer
and 0.3U of Phusion DNA polymerase (Thermo Scientific).
Five to ten replicates were performed to produce suffi-
cient DNA product for library generation and sequen-
cing. Additionally, to enable monitoring of the reaction
using qPCR, duplicates were included containing 0.5x
SYBR Green 1 (Life Technologies). PCR cycling con-
ditions were 98°C for 30s, followed by a variable
number of cycles of 98°C for 10s and 72°C for 1 min. PCR
cycles were selected either to minimise PCR-induced
chimera formation (25–29 cycles) or to maximise DNA
product and to ‘stress’ PCR conditions (35-40cycles).
Library generation and 454 sequencing
PCR replicates were pooled and purified using the
Wizard SV gel and PCR Clean-Up System (Promega)following the recommended protocol and quantitated
against a plasmid standard curve, generated with gag1
amplicon, ranging from 102-106 copies of DNA per
microlitre. Aliquots of each amplicon (gag1-gag4) for each
sample were pooled to construct sequencing libraries
using the 454 library preparation kit (Roche). Emulsion
PCR and sequencing were performed using standard
XLR70 chemistry at the Institute for Immunology and
Infectious Diseases, Perth, Australia.
Statistical analysis
Sequencing analysis was performed using software custom
written in BioRuby. Chimera formation, expressed as
recombination rate per 1000 nucleotides (REPN), and
statistical comparisons performed as previously described
[7]. Recombination is detected by monitoring the linking
of marker points in the HIV-1 gag gene from WTand MK
genomes into a single chimeric genome.
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